相关实验视频

Updated: Jul 21, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

双抗血小板疗法:临床医生的简要评论

Hafeez Ul Hassan Virk¹, Johao Escobar², Mario Rodriguez³

¹Harrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH 44101, USA.

Life (Basel, Switzerland)

|July 29, 2023

概括

优化双抗血小板治疗 (DAPT) 持续时间平衡,防止血栓事件和出血风险. 短期的DAPT是皮肤穿刺冠状动脉干预后有效的,而更长的持续时间需要仔细评估风险.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
临床医学临床医学

背景情况:

双抗血小板治疗 (DAPT) 对于治疗动脉样硬化心血管疾病至关重要.
新兴的研究不断完善最佳的DAPT持续时间,平衡疗效和出血风险.
个性化方法对于将DAPT定制到个体患者的个人资料至关重要.

研究的目的:

审查各种心血管疾病中DAPT持续时间的现有证据.
分析与不同的DAPT持续时间相关的好处和风险.
为指导临床决策对抗血小板治疗的选择和持续时间.

主要方法:

对最近的临床试验和指导方针进行系统审查.
对DAPT疗效和安全结果的数据分析.
在特定患者群体中对DAPT的评估 (例如,急性冠状动脉综合征,稳定冠状动脉疾病,心房动,术后设置).

主要成果:

短期DAPT (1-6个月) 在急性冠状动脉综合征的皮肤穿后冠状动脉干预是有效的.
长时间的DAPT (12个月以上) 减少了血栓事件,但增加了出血风险.
扩展的DAPT在稳定的冠状动脉疾病中提供了有限的益处;特异性药物如蒂卡格勒勒/阿司匹林显示出混合的结果,增加出血.
根据临床情景,患者的风险因素和特定干预措施 (例如PCI,CABG,TAVI,PAD,心血管疾病),DAPT的持续时间有很大的不同.

结论:

最佳的DAPT持续时间需要仔细考虑个体患者的特征,出血风险和特定的临床背景.
联合抗血小板疗法可能有好处,但需要进行彻底的风险-好处评估.
需要进一步的研究,以优化各种患者群体和临床场景的抗血小板策略.

关键词:

DAPT DAPT 是一个应用程序.双重抗血小板疗法双重抗血小板疗法

更多相关视频

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Ferric Chloride-induced Murine Thrombosis Models

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...